Earnings NewsHealthcareCTI BioPharma misses by $0.03, beats on revenueNov. 08, 2016 5:06 PM ETCTI BioPharma Corp. (CTIC) StockBy: Gaurav Batavia, SA News Editor1 Comment CTI BioPharma (NASDAQ:CTIC): Q3 EPS of -$0.10 misses by $0.03. Revenue of $4.44M (+362.5% Y/Y) beats by $0.49M. Press Release Recommended For YouRelated StocksSymbolLast Price% ChgCTIC--CTI BioPharma Corp.Trending AnalysisTrending News